These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 15030347)

  • 21. 'Until diarrhea occurs'? There's a maximum dosage to prevent colchicine toxicity.
    Lilley LL; Guanci R
    Am J Nurs; 1999 Apr; 99(4):12. PubMed ID: 10234309
    [No Abstract]   [Full Text] [Related]  

  • 22. Fatal toxic epidermal necrolysis due to lansoprazole.
    Heaton NR; Edmonds EV; Francis ND; Bunker CB; Bowling JC; Morar N
    Clin Exp Dermatol; 2004 Nov; 29(6):612-3. PubMed ID: 15550134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Skin reaction from colchicine].
    Vittori F; Liautard C; Riou V
    Therapie; 2001; 56(1):63-5. PubMed ID: 11322022
    [No Abstract]   [Full Text] [Related]  

  • 24. Potentially fatal interaction between colchicine and disulfiram.
    Chen SC; Huang MC; Fan CC
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1281. PubMed ID: 19580840
    [No Abstract]   [Full Text] [Related]  

  • 25. Toxic epidermal necrolysis probably due to Klebsiella pneumoniae sepsis.
    de Groot R; Oranje AP; Vuzevski VD; Mettau JW
    Dermatologica; 1984; 169(2):88-90. PubMed ID: 6383893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of colchicine toxicity in patients with gout.
    Dalbeth N; Gow P
    N Z Med J; 2007 Apr; 120(1252):U2503. PubMed ID: 17460750
    [No Abstract]   [Full Text] [Related]  

  • 27. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel.
    Halevy S; Ghislain PD; Mockenhaupt M; Fagot JP; Bouwes Bavinck JN; Sidoroff A; Naldi L; Dunant A; Viboud C; Roujeau JC;
    J Am Acad Dermatol; 2008 Jan; 58(1):25-32. PubMed ID: 17919772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colchicine in acute gout.
    Morris I; Varughese G; Mattingly P
    BMJ; 2003 Nov; 327(7426):1275-6. PubMed ID: 14644973
    [No Abstract]   [Full Text] [Related]  

  • 29. Colchicine intoxication and infection risk: a case report.
    Kocak Z; Akay H; Gucenmez S; Tufan A; Donderici O
    J Clin Pharm Ther; 2008 Aug; 33(4):451-2. PubMed ID: 18613863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colchicine myoneuropathy in a renal transplant patient.
    Dupont P; Hunt I; Goldberg L; Warrens A
    Transpl Int; 2002 Jul; 15(7):374-6. PubMed ID: 12122515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxic epidermal necrolysis: an image case.
    Ashworth SW
    Ann Emerg Med; 2005 Feb; 45(2):109, 156. PubMed ID: 15671964
    [No Abstract]   [Full Text] [Related]  

  • 32. Unrecognized fatalities related to colchicine in hospitalized patients.
    Mullins M; Cannarozzi AA; Bailey TC; Ranganathan P
    Clin Toxicol (Phila); 2011 Aug; 49(7):648-52. PubMed ID: 21740149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colchicine myoneuropathy in chronic renal failure patients with gout.
    Lai IC; Cheng CY; Chen HH; Chen WY; Chen PY
    Nephrology (Carlton); 2006 Apr; 11(2):147-50. PubMed ID: 16669978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fatal pristinamycin-induced toxic epidermal necrolysis (Lyell's syndrome): difficulties in attributing causal association in the polymedicated intensive care unit patient.
    Chanques G; Girard C; Pinzani V; Jaber S
    Acta Anaesthesiol Scand; 2005 May; 49(5):721-2. PubMed ID: 15836693
    [No Abstract]   [Full Text] [Related]  

  • 35. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population.
    Tassaneeyakul W; Jantararoungtong T; Chen P; Lin PY; Tiamkao S; Khunarkornsiri U; Chucherd P; Konyoung P; Vannaprasaht S; Choonhakarn C; Pisuttimarn P; Sangviroon A; Tassaneeyakul W
    Pharmacogenet Genomics; 2009 Sep; 19(9):704-9. PubMed ID: 19696695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Near fatal acute colchicine intoxication in a child. A case report.
    Goldbart A; Press J; Sofer S; Kapelushnik J
    Eur J Pediatr; 2000 Dec; 159(12):895-7. PubMed ID: 11131346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possible colchicine rhabdomyolysis in a fluvastatin-treated patient.
    Atasoyu EM; Evrenkaya TR; Solmazgul E
    Ann Pharmacother; 2005; 39(7-8):1368-9. PubMed ID: 15956236
    [No Abstract]   [Full Text] [Related]  

  • 38. Severe respiratory muscle weakness related to long-term colchicine therapy.
    Tanios MA; El Gamal H; Epstein SK; Hassoun PM
    Respir Care; 2004 Feb; 49(2):189-91. PubMed ID: 14744269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colchicine in acute gout.
    Morgan L
    Aust Fam Physician; 2008 Mar; 37(3):103; author reply 103. PubMed ID: 18376515
    [No Abstract]   [Full Text] [Related]  

  • 40. Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus.
    Paradela S; Martínez-Gómez W; Fernández-Jorge B; Castiñeiras I; Yebra-Pimentel T; Llinares P; Fonseca Capdevila E
    Lupus; 2007; 16(9):741-5. PubMed ID: 17728369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.